<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37947104</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2150-1327</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Journal of primary care &amp; community health</Title><ISOAbbreviation>J Prim Care Community Health</ISOAbbreviation></Journal><ArticleTitle>Clinical Characterization of the Persistent COVID-19 Symptoms: A Descriptive Observational Study in Primary Care.</ArticleTitle><Pagination><StartPage>21501319231208283</StartPage><MedlinePgn>21501319231208283</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">21501319231208283</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/21501319231208283</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Evidence and clinical experience suggest that there are a range of signs of health issues that affect patients who have recovered from acute COVID-19 infection. This condition is commonly referred to as "persistent COVID-19," which is not connected with the severity of the disease. We have identified the prevalence and clinical-epidemiological characteristics of patients with COVID-19 and persistent symptoms treated in primary care centers. This is a descriptive observational study conducted between December 2020 and May 2022, the data were collected from digitized medical records and interviewing 1542 individuals with laboratory-confirmed SARS-CoV-2 infection. These patients were clinically followed for up to 1&#x2009;year, based on the prevalence of symptoms. When stratifying by the risk of developing persistent COVID-19, 37.09% of the patients exhibited risk factors, with age (over 60&#x2009;years) and cardiovascular risk factors predominating. The obtained prevalence of persistent COVID-19 at 90&#x2009;days was 12.39%, with a slight predominance in females (55%) and a mean age of 45.8&#x2009;years. The most affected systems were the cardiovascular, respiratory, and psychoneurological systems, with predominant symptoms of fatigue (41.88%), dyspnea (32.46%), and headache (14.66%), among others. The average duration of persistent symptoms was 178&#x2009;days, equivalent to 6&#x2009;months. In conclusion, over 10% of patients who recover from acute SARS-CoV-2 infection developed long-term consequences.</AbstractText><AbstractText Label="OBJECTIVE">To measure the prevalence and clinical-epidemiological characteristics of individuals diagnosed with COVID-19 and persistent symptoms treated in primary care centers in &#xc1;rea Sanitaria Sur de C&#xf3;rdoba (Spain) between December 2020 and May 2022.</AbstractText><AbstractText Label="METHODS">A retrospective observational study of the population of &#xc1;rea Sanitaria Sur de C&#xf3;rdoba was developed between December 2020 and May 2022. The scope of the study was 1542 individuals, and the prevalence of patients diagnosed with COVID-19 and persistent symptoms was determined based on laboratory-confirmed cases, randomly selected from adults who had progressed beyond the acute phase of the disease. All data were managed by the &#xc1;rea Sanitaria Sur de C&#xf3;rdoba (Spain).</AbstractText><AbstractText Label="RESULTS">The risk factor of exhibiting one or more risk factors associated with developing persistent COVID-19 is 37.09%. The obtained prevalence of persistent COVID-19 at 90&#x2009;days is 12.39%, it is higher in females (55%) than males and the mean age was 45.8&#x2009;years. The most affected systems were the cardiovascular, respiratory, and psychoneurological systems, with predominant symptoms of fatigue (41.88%), dyspnea (32.46%), and headache (14.66%), among others.</AbstractText><AbstractText Label="CONCLUSIONS">Results confirm that more than 10% of individuals recovering from acute SARS-CoV-2 infection showed long-term consequences and the observed persistent symptom duration was 178&#x2009;days on average.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodr&#xed;guez Onieva</LastName><ForeName>Araceli</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0009-9691-4627</Identifier><AffiliationInfo><Affiliation>&#xc1;rea Sanitaria Sur de C&#xf3;rdoba, UGC Lucena, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallejo Basurte</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>&#xc1;rea Sanitaria Sur de C&#xf3;rdoba, UGC Rute, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez Bersab&#xe9;</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>&#xc1;rea Sanitaria Sur de C&#xf3;rdoba, UGC Benameji, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camacho Cerro</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>&#xc1;rea Sanitaria Sur de C&#xf3;rdoba, UGC Lucena, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valverde Basc&#xf3;n</LastName><ForeName>Borja</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>&#xc1;rea Sanitaria Sur de C&#xf3;rdoba, UGC Lucena, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muriel Sanjuan</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>&#xc1;rea Sanitaria Sur de C&#xf3;rdoba, UGC Lucena, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soto Castro</LastName><ForeName>Celina Ang&#xe9;lica</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>&#xc1;rea Sanitaria Sur de C&#xf3;rdoba, UGC Almedinilla/Priego de C&#xf3;rdoba, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a Morales</LastName><ForeName>Ver&#xf3;nica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>&#xc1;rea Sanitaria Sur de C&#xf3;rdoba, UGC Cabra, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piedra Ruiz</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>&#xc1;rea Sanitaria Sur de C&#xf3;rdoba UGC Izn&#xe1;jar/Rute, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hidalgo Requena</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6810-5621</Identifier><AffiliationInfo><Affiliation>&#xc1;rea Sanitaria Sur de C&#xf3;rdoba, UGC Lucena, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Prim Care Community Health</MedlineTA><NlmUniqueID>101518419</NlmUniqueID><ISSNLinking>2150-1319</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">persistent COVID-19</Keyword><Keyword MajorTopicYN="N">primary health care</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2</Keyword></KeywordList><CoiStatement>Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>10</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37947104</ArticleId><ArticleId IdType="pmc">PMC10638863</ArticleId><ArticleId IdType="doi">10.1177/21501319231208283</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Del Rio C, Collins LF, Malani P. Long-term health consequences of COVID-19. JAMA. 2020;324(17):1723-1724. doi:10.1001/jama.2020.19719</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al.. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. medRxiv. 2021. doi:10.1101/2021.01.27.21250617</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez Ledo P, Armenteros del Olmo L, Rodr&#xed;guez Rodr&#xed;guez E, G&#xf3;mez Acebo F; en representaci&#xf3;n de Sociedad Espa&#xf1;ola de M&#xe9;dicos Generales y de Familia (SEMG) y colectivo Long COVID ACTS. Descripci&#xf3;n de los 201 s&#xed;ntomas de la afectaci&#xf3;n multiorg&#xe1;nica producida en los pacientes afectados por la COVID-19 persistente. Med Gen Fam. 2021;10(2):60-68. doi:10.24038/mgyf.2021.016</Citation><ArticleIdList><ArticleId IdType="doi">10.24038/mgyf.2021.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al.. Long COVID in the Faroe Islands: a longitudinal study among nonhospitalized patients. Clin Infect Dis. 2021;73(11): e4058-e4063. doi:10.1093/cid/ciaa1792</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health Research. Living with Covid19. National Institute for Health Research; 2020. doi:10.3310/themedreview_41169</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/themedreview_41169</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al.. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2020;27(1):89-95. doi:10.1016/j.cmi.2020.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F; for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603. doi:10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O&#x2019;Brien K, et al.. Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc. 2021;18(6):997-1003. doi:10.1513/AnnalsATS.202009-1175OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al.. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2): 258-263. doi:10.1016/j.cmi.2020.09.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>
Fundaci&#xf3;n AstraZeneca. Documento para laatenci&#xf3;n integralal paciente post-COVID. 2020. https://sedisa.net/2021/02/15/documento-para-la-atencion-integral-al-paciente-post-covid/</Citation></Reference><Reference><Citation>Mahase E. Covid-19: What do we know about &#x201c;long covid&#x201d;? BMJ. Published online July 14, 2020. doi:10.1136/bmj.m2815</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta EM, Spallone A, Rodriguez-Barradas MC, et al.. Postacute COVID-19: an overview and approach to classification. Open Forum Infect Dis. 2020;7(12):1-7. doi:10.1093/ofid/ofaa509</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa509</ArticleId><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4): e102-e107. doi:10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO. WHO China joint mission on Covid19 final report. Published online 2020. Accessed March 16, 2021. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf</Citation></Reference><Reference><Citation>
Covid prolongado&#xbb; podr&#xed;a ser varios s&#xed;ndromes diferentes - Noticias m&#xe9;dicas - IntraMed [Internet]. October
16, 2020. Accessed March 16, 2021. https://www.intramed.net/contenidover.asp?contenidoid=96952.</Citation></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al..; IVY Network Investigators, CDC COVID-19 Response Team, IVY Network Investigators, CDC COVID-19 Response Team. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network &#x2014; United States, March&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al..; ARC Study Group. Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396-398. doi:10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al.. Author Correction: attributes and predictors of long covid. Nat Med. 2021;27(6):1116-1631. doi:10.1038/s41591-021-01361-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01361-2</ArticleId><ArticleId IdType="pubmed">34045738</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Sampalo A, Bernal-L&#xf3;pez MR, G&#xf3;mez-Huelgas R. [Persistent COVID-19 syndrome. A narrative review]. Rev Clin Esp. 2022;222(4):241-250. doi:10.1016/j.rce.2021.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rce.2021.10.003</ArticleId><ArticleId IdType="pmc">PMC8882405</ArticleId><ArticleId IdType="pubmed">35260380</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Rodr&#xed;guez E, Perula-de-Torres L&#xc1;, Gonz&#xe1;lez-Lama J, et al.. Long COVID symptomatology and associated factors in primary care patients: the EPICOVID-AP21 study. Healthcare. 2023;11(2):218. doi:10.3390/healthcare11020218</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11020218</ArticleId><ArticleId IdType="pmc">PMC9858944</ArticleId><ArticleId IdType="pubmed">36673587</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Ye L, Xia R, et al.. Chest computed tomography and clinical Follow-Up of discharged patients with COVID-19 in Wenzhou City, Zhejiang, China. Annals ATS. 2020;17(10):1231-1237. doi:10.1513/AnnalsATS.202004-324OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202004-324OC</ArticleId><ArticleId IdType="pmc">PMC7640627</ArticleId><ArticleId IdType="pubmed">32692945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang YM, Song WB, et al.. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. med. 2020;25:1-9. doi:10.1016/j.eclinm.2020.100463</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsat ND, Palmowski A, Palmowski Y, Boers M, Buttgereit F. Recruitment and retention of older people in clinical research: a systematic literature review. J Am Geriatr Soc. 2020;68(12): 2955-2963. doi:10.1111/jgs.16875</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16875</ArticleId><ArticleId IdType="pubmed">33075140</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, et al.. The Post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56(1):2001494. doi:10.1183/13993003.01494-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, et al.. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open. 2022;5(10):e2238804. doi:10.1001/jamanetworkopen.2022.38804</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, et al.. The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. 2023;55:1-10. doi:10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y. Expression of concern: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2022;401(10371):90-232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC9691145</ArticleId><ArticleId IdType="pubmed">36436530</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, et al.. Risk factors associated with long COVID syndrome: a retrospective study. Iran J Med Sci. 2021;46(6):428-436. doi:10.30476/ijms.2021.92080.2326</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Owusu D, Kim L, O&#x2019;Halloran A, et al..; COVID-NET Surveillance Team. Characteristics of adults aged 18-49 years without underlying conditions hospitalized with laboratory-confirmed Coronavirus Disease 2019 in the United States: COVID-NET-March-August 2020. Clin Infect Dis. 2021;72(5):e162-e166. doi:10.1093/cid/ciaa1806</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1806</ArticleId><ArticleId IdType="pmc">PMC7799269</ArticleId><ArticleId IdType="pubmed">33270136</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Machado FVC, Meys R, et al.. Care dependency in non-hospitalized patients with COVID-19. J Clin Med. 2020;9(9):2946. doi:10.3390/jcm9092946</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092946</ArticleId><ArticleId IdType="pmc">PMC7564703</ArticleId><ArticleId IdType="pubmed">32932582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayuso Garc&#xed;a B, P&#xe9;rez L&#xf3;pez A, Besteiro Balado Y, et al.. Calidad de vida relacionada con la salud en pacientes recuperados de COVID-19. J Heal Qual Res. 2022;37(4):208-215. doi:10.1016/j.jhqr.2022.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhqr.2022.01.001</ArticleId><ArticleId IdType="pmc">PMC8761545</ArticleId><ArticleId IdType="pubmed">35125340</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinzon RT, Wijaya VO, Jody AA, Nunsio PN, Buana RB. Persistent neurological manifestations in long COVID-19 syndrome: a systematic review and meta-analysis. J Infect Public Health. 2022;15(8):856-869. doi:10.1016/j.jiph.2022.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.06.013</ArticleId><ArticleId IdType="pmc">PMC9221935</ArticleId><ArticleId IdType="pubmed">35785594</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>